semaglutide compounding pharmacy ban Compounded' weight-loss drugs are a growing problem for state regulators • Stateline Some seeking weight-loss drug risk

This is standard protocol, not optional

Common adverse effects include nausea, vomiting, diarrhoea, constipation, and abdominal pain, which are usually mild to moderate and diminish over time as the dose is gradually increased

10.1111/cbdd.12615 126

Tirzepatide generally shows greater average weight reduction, while semaglutide has a longer clinical history and more extensive real-world use data

GHD is documented in 40-100% of children with PWS, although the severity can vary from mild to severe ( The cause of impaired GH secretion in PWS is still being debated, mainly because early childhood-onset obesity is so common in this population